Appropriateness of Age Thresholds for Respiratory Syncytial Virus Immunoprophylaxis in Moderate-Preterm Infants

JAMA Pediatrics - United States
doi 10.1001/jamapediatrics.2013.2636
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Correction To: Cost-Effectiveness of Rule-Based Immunoprophylaxis Against Respiratory Syncytial Virus Infections in Preterm Infants

European Journal of Pediatrics
Child HealthPediatricsPerinatology
2019English

Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2017English

Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants

PharmacoEconomics - Open
Health PolicyPharmacology
2017English

770 Pathogenesis of Respiratory Syncytial (Rs) Virus Bronchiolitis in Infants

Pediatric Research
Child HealthPediatricsPerinatology
1978English

Predictors and Incidence of Hospitalization Due to Respiratory Syncytial Virus (RSV)-associated Lower Respiratory Tract Infection (LRTI) in Non-Prophylaxed Moderate-To-Late Preterm Infants in Bosnia and Herzegovina

Bosnian Journal of Basic Medical Sciences
Medicine
2018English

Respiratory Syncytial Virus Lower Respiratory Tract Infections in Premature Infants and Infants With Bronchopulmonary Dysplasia

CHILDREN INFECTIONS
2015English

Indications to Respiratory Syncytial Virus Immunoprophylaxis in the 29–32 wGA Group: Is There Still Room for Debating?

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2017English

Respiratory Syncytial Virus

JAMA - Journal of the American Medical Association
Medicine
2017English

Respiratory Syncytial Virus

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy